Ten‐year work burden after prostate cancer treatment
Abstract Introduction We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. Materials and Methods We identified men diagnosed with PCa treated with r...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.6530 |
| _version_ | 1827386788217356288 |
|---|---|
| author | Samuel L. Washington III Peter E. Lonergan Janet E. Cowan Shoujun Zhao Jeanette M. Broering Nynikka R. Palmer Cameron Hicks Matthew R. Cooperberg Peter R. Carroll |
| author_facet | Samuel L. Washington III Peter E. Lonergan Janet E. Cowan Shoujun Zhao Jeanette M. Broering Nynikka R. Palmer Cameron Hicks Matthew R. Cooperberg Peter R. Carroll |
| author_sort | Samuel L. Washington III |
| collection | DOAJ |
| description | Abstract Introduction We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. Materials and Methods We identified men diagnosed with PCa treated with radical prostatectomy, radiation therapy, or active surveillance/watchful waiting within CaPSURE. Patients self‐reported work burden and SF36 general health scores via surveys before and 1,3,5, and 10 years after treatment. Using multivariate repeated measures generalized estimating equation modeling we examined the association between primary treatment with risk of any work weeks lost due to care. Results In total, 6693 men were included. The majority were White (81%, 5% Black, and 14% Other) with CAPRA low‐ (60%) or intermediate‐risk (32%) disease and underwent surgery (62%) compared to 29% radiation and 9% active surveillance. Compared to other treatments, surgical patients were more likely to report greater than 7 days off work in the first year, with relatively less time off over time. Black men (RR 0.64, 95% CI 0.54–0.77) and those undergoing radiation (vs. surgery, RR 0.46, 95% CI 0.41–0.51) were less likely to report time off from work over time. Mean baseline GH score (73 [SD 18]) was similar between race and treatment groups, and stable over time. Conclusions The work burden of cancer care continued up to 10 years after treatment and varied across racial groups and primary treatment groups, highlighting the multifactorial nature of this issue and the call to leverage greater resources for those at greatest risk. |
| first_indexed | 2024-03-08T15:51:38Z |
| format | Article |
| id | doaj.art-56ad4364eed64abcb3d7370d8bc0a82f |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-03-08T15:51:38Z |
| publishDate | 2023-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-56ad4364eed64abcb3d7370d8bc0a82f2024-01-09T05:21:16ZengWileyCancer Medicine2045-76342023-09-011218192341924410.1002/cam4.6530Ten‐year work burden after prostate cancer treatmentSamuel L. Washington III0Peter E. Lonergan1Janet E. Cowan2Shoujun Zhao3Jeanette M. Broering4Nynikka R. Palmer5Cameron Hicks6Matthew R. Cooperberg7Peter R. Carroll8Department of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Urology St. James's Hospital Dublin IrelandDepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Surgery University of California San Francisco California USADepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USADepartment of Urology, Helen Diller Family Comprehensive Cancer Center University of California San Francisco California USAAbstract Introduction We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10‐year period after PCa diagnosis and identify those at greatest risk. Materials and Methods We identified men diagnosed with PCa treated with radical prostatectomy, radiation therapy, or active surveillance/watchful waiting within CaPSURE. Patients self‐reported work burden and SF36 general health scores via surveys before and 1,3,5, and 10 years after treatment. Using multivariate repeated measures generalized estimating equation modeling we examined the association between primary treatment with risk of any work weeks lost due to care. Results In total, 6693 men were included. The majority were White (81%, 5% Black, and 14% Other) with CAPRA low‐ (60%) or intermediate‐risk (32%) disease and underwent surgery (62%) compared to 29% radiation and 9% active surveillance. Compared to other treatments, surgical patients were more likely to report greater than 7 days off work in the first year, with relatively less time off over time. Black men (RR 0.64, 95% CI 0.54–0.77) and those undergoing radiation (vs. surgery, RR 0.46, 95% CI 0.41–0.51) were less likely to report time off from work over time. Mean baseline GH score (73 [SD 18]) was similar between race and treatment groups, and stable over time. Conclusions The work burden of cancer care continued up to 10 years after treatment and varied across racial groups and primary treatment groups, highlighting the multifactorial nature of this issue and the call to leverage greater resources for those at greatest risk.https://doi.org/10.1002/cam4.6530disease managementprostate cancerracial groupswork burden |
| spellingShingle | Samuel L. Washington III Peter E. Lonergan Janet E. Cowan Shoujun Zhao Jeanette M. Broering Nynikka R. Palmer Cameron Hicks Matthew R. Cooperberg Peter R. Carroll Ten‐year work burden after prostate cancer treatment Cancer Medicine disease management prostate cancer racial groups work burden |
| title | Ten‐year work burden after prostate cancer treatment |
| title_full | Ten‐year work burden after prostate cancer treatment |
| title_fullStr | Ten‐year work burden after prostate cancer treatment |
| title_full_unstemmed | Ten‐year work burden after prostate cancer treatment |
| title_short | Ten‐year work burden after prostate cancer treatment |
| title_sort | ten year work burden after prostate cancer treatment |
| topic | disease management prostate cancer racial groups work burden |
| url | https://doi.org/10.1002/cam4.6530 |
| work_keys_str_mv | AT samuellwashingtoniii tenyearworkburdenafterprostatecancertreatment AT peterelonergan tenyearworkburdenafterprostatecancertreatment AT janetecowan tenyearworkburdenafterprostatecancertreatment AT shoujunzhao tenyearworkburdenafterprostatecancertreatment AT jeanettembroering tenyearworkburdenafterprostatecancertreatment AT nynikkarpalmer tenyearworkburdenafterprostatecancertreatment AT cameronhicks tenyearworkburdenafterprostatecancertreatment AT matthewrcooperberg tenyearworkburdenafterprostatecancertreatment AT peterrcarroll tenyearworkburdenafterprostatecancertreatment |